13F HOLDINGS REPORT
Seven Fleet Capital Management LP
Quarter ended Q4 2025 · Filed February 26, 2026 · Accession 0001013594-26-000305
Total Value
$131.5M
Positions
87
Other Managers
1
Confidential Omitted
No
Holdings (87)
| # | Issuer | Ticker / CUSIP | Shares | Value | % of Filing |
|---|---|---|---|---|---|
| 1 | CG ONCOLOGY INC | CGON | 1,439,393 | $59.8M | 45.45% |
| 2 | REVOLUTION MEDICINES INC | RVMDW | 65,800 | $5.2M | 3.99% |
| 3 | SOLENO THERAPEUTICS INC | SLNO | 76,079 | $3.5M | 2.68% |
| 4 | LIQUIDIA CORPORATION | LQDA | 91,267 | $3.1M | 2.39% |
| 5 | CG ONCOLOGY INC | CGON | 75,758 | $3.1M | 2.39% |
| 6 | COMPASS THERAPEUTICS INC | CMPX | 568,747 | $3.1M | 2.32% |
| 7 | EXELIXIS INC | EXEL | 68,569 | $3.0M | 2.29% |
| 8 | SOLENO THERAPEUTICS INC | SLNO | 54,000 | $2.5M | 1.90% |
| 9 | AXSOME THERAPEUTICS INC | AXSM | 12,955 | $2.4M | 1.80% |
| 10 | TYRA BIOSCIENCES INC | TYRA | 79,560 | $2.1M | 1.59% |
| 11 | COGENT BIOSCIENCES INC | COGT | 54,025 | $1.9M | 1.46% |
| 12 | TANGO THERAPEUTICS INC | TNGX | 215,172 | $1.9M | 1.45% |
| 13 | XENCOR INC | XNCR | 109,554 | $1.7M | 1.28% |
| 14 | PHARVARIS N V | PHVS | 55,342 | $1.5M | 1.17% |
| 15 | TERNS PHARMACEUTICALS INC | TERN | 36,894 | $1.5M | 1.13% |
| 16 | BELITE BIO INC | BLTE | 9,161 | $1.5M | 1.11% |
| 17 | DYNE THERAPEUTICS INC | DYN | 70,180 | $1.4M | 1.04% |
| 18 | NUVALENT INC | NUVL | 12,601 | $1.3M | 0.96% |
| 19 | ASCENDIS PHARMA A/S | ASND | 5,670 | $1.2M | 0.92% |
| 20 | AMICUS THERAPEUTICS INC | FOLD | 82,500 | $1.2M | 0.89% |
| 21 | VAXCYTE INC | PCVX | 25,365 | $1.2M | 0.89% |
| 22 | AVALO THERAPEUTICS INC | AVTX | 63,343 | $1.2M | 0.87% |
| 23 | INHIBIKASE THERAPEUTICS INC | IKT | 533,648 | $1.1M | 0.83% |
| 24 | MADRIGAL PHARMACEUTICALS INC | MDGL | 1,860 | $1.1M | 0.82% |
| 25 | GERON CORP | GERN | 777,880 | $1.0M | 0.78% |
| 26 | KRYSTAL BIOTECH INC | KRYS | 4,000 | $986,160 | 0.75% |
| 27 | ATHIRA PHARMA INC | 04746L203 | 127,951 | $968,589 | 0.74% |
| 28 | TAYSHA GENE THERAPIES INC | TSHA | 167,223 | $919,727 | 0.70% |
| 29 | SILENCE THERAPEUTICS PLC | SLNCF | 147,600 | $897,408 | 0.68% |
| 30 | ZURA BIO LTD | ZURA | 166,500 | $872,460 | 0.66% |
| 31 | AGIOS PHARMACEUTICALS INC | AGIO | 31,738 | $863,908 | 0.66% |
| 32 | PRAXIS PRECISION MEDICINES I | PRAX | 2,700 | $795,798 | 0.61% |
| 33 | CELCUITY INC | CELC | 7,849 | $782,859 | 0.60% |
| 34 | KALVISTA PHARMACEUTICALS INC | KALV | 48,412 | $781,854 | 0.59% |
| 35 | PALISADE BIO INC | PALI | 327,500 | $769,625 | 0.59% |
| 36 | RELMADA THERAPEUTICS INC | RLMD | 154,109 | $744,346 | 0.57% |
| 37 | PROTAGONIST THERAPEUTICS INC | PTGX | 8,000 | $698,720 | 0.53% |
| 38 | CIDARA THERAPEUTICS INC | 171757206 | 3,026 | $668,413 | 0.51% |
| 39 | CYTOKINETICS INC | CYTK | 10,335 | $656,686 | 0.50% |
| 40 | NEKTAR THERAPEUTICS | NKTR | 15,000 | $634,200 | 0.48% |
| 41 | UNITED THERAPEUTICS CORP DEL | UTHR | 130,000 | $633,425 | 0.48% |
| 42 | RELAY THERAPEUTICS INC | RLAY | 73,000 | $617,580 | 0.47% |
| 43 | DIANTHUS THERAPEUTICS INC | DNTH | 14,651 | $603,768 | 0.46% |
| 44 | MBX BIOSCIENCES INC | MBX | 18,200 | $574,028 | 0.44% |
| 45 | MINERALYS THERAPEUTICS INC | MLYS | 15,243 | $553,168 | 0.42% |
| 46 | EVOLUS INC | EOLS | 82,000 | $545,300 | 0.41% |
| 47 | ZYMEWORKS INC | ZYME | 20,600 | $542,398 | 0.41% |
| 48 | CORBUS PHARMACEUTICALS HLDGS | CRBP | 56,750 | $461,945 | 0.35% |
| 49 | VIRIDIAN THERAPEUTICS INC | VRDN | 14,654 | $456,032 | 0.35% |
| 50 | PROTHENA CORP PLC | PRTA | 43,300 | $413,515 | 0.31% |
| 51 | NURIX THERAPEUTICS INC | NRIX | 20,000 | $379,400 | 0.29% |
| 52 | SAVARA INC | SVRA | 62,762 | $378,455 | 0.29% |
| 53 | TARSUS PHARMACEUTICALS INC | TARS | 4,500 | $368,460 | 0.28% |
| 54 | PLIANT THERAPEUTICS INC | PLRX | 276,500 | $337,330 | 0.26% |
| 55 | ACLARIS THERAPEUTICS INC | ACRS | 107,419 | $323,331 | 0.25% |
| 56 | SEPTERNA INC | SEPN | 11,445 | $319,087 | 0.24% |
| 57 | CLIMB BIO INC | CLYM | 76,400 | $305,600 | 0.23% |
| 58 | COMPASS PATHWAYS PLC | CMPS | 40,000 | $276,000 | 0.21% |
| 59 | ENTERA BIO LTD | ENTX | 135,318 | $262,517 | 0.20% |
| 60 | VIKING THERAPEUTICS INC | VKTX | 6,000 | $211,080 | 0.16% |
| 61 | UNIQURE NV | QURE | 8,742 | $209,196 | 0.16% |
| 62 | CYTOMX THERAPEUTICS INC | CTMX | 48,898 | $208,305 | 0.16% |
| 63 | OCULAR THERAPEUTIX INC | OCUL | 17,100 | $207,594 | 0.16% |
| 64 | ENLIVEN THERAPEUTICS INC | ELVN | 11,688 | $179,995 | 0.14% |
| 65 | ORUKA THERAPEUTICS INC | ORKA | 5,240 | $158,824 | 0.12% |
| 66 | ASSEMBLY BIOSCIENCES INC | ASMB | 4,315 | $146,753 | 0.11% |
| 67 | NEWAMSTERDAM PHARMA COMPANY | NAMSW | 4,000 | $140,320 | 0.11% |
| 68 | AMYLYX PHARMACEUTICALS INC | AMLX | 11,571 | $139,778 | 0.11% |
| 69 | APOGEE THERAPEUTICS INC | APGE | 1,800 | $135,864 | 0.10% |
| 70 | ALX ONCOLOGY HLDGS INC | ALXO | 117,817 | $133,133 | 0.10% |
| 71 | VERASTEM INC | VSTM | 15,140 | $116,881 | 0.09% |
| 72 | REGENCELL BIOSCIENCE HLDGS L | RGC | 4,400 | $92,400 | 0.07% |
| 73 | TREVI THERAPEUTICS INC | TRVI | 7,110 | $89,017 | 0.07% |
| 74 | IMMUNIC INC | IMUX | 155,223 | $82,843 | 0.06% |
| 75 | PMV PHARMACEUTICALS INC | PMVP | 63,498 | $79,373 | 0.06% |
| 76 | MONTE ROSA THERAPEUTICS INC | GLUE | 4,000 | $62,720 | 0.05% |
| 77 | TRAWS PHARMA INC | TRAW | 49,260 | $55,664 | 0.04% |
| 78 | ASTRIA THERAPEUTICS INC | 04635X102 | 4,000 | $52,360 | 0.04% |
| 79 | EDGEWISE THERAPEUTICS INC | EWTX | 2,000 | $49,630 | 0.04% |
| 80 | VISTAGEN THERAPEUTICS INC | VTGN | 62,701 | $41,502 | 0.03% |
| 81 | ENANTA PHARMACEUTICALS INC | ENTA | 2,270 | $35,798 | 0.03% |
| 82 | CULLINAN THERAPEUTICS INC | CGEM | 3,000 | $31,050 | 0.02% |
| 83 | GENERATION BIO CO | 37148K209 | 5,376 | $30,536 | 0.02% |
| 84 | BEAM THERAPEUTICS INC | BEAM | 337 | $9,342 | 0.01% |
| 85 | ELEDON PHARMACEUTICALS ORD | ELDN | 6,000 | $9,060 | 0.01% |
| 86 | ABIVAX SA | AAVXF | 12 | $1,618 | 0.00% |
| 87 | VIR BIOTECHNOLOGY INC | VIR | 200 | $1,206 | 0.00% |